(1 reference)-
- 抗原 See all IDO 抗体
- IDO (Indoleamine 2,3-Dioxygenase (IDO))
-
抗原表位
- AA 78-184
-
适用
- 人, 小鼠
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This IDO antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 交叉反应
- 小鼠
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 免疫原
- Peptide corresponding to amino acids 78-184 of human IDO fused to GST.
- 克隆位点
- 10-1
- 亚型
- IgG3
- Top Product
- Discover our top product IDO Primary Antibody
-
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 2-403) antibody
IDO 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 2-403) antibodyIDO 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C13 unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 106-190) antibodyIDO 适用: 大鼠 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 276-360) antibodyIDO 适用: 大鼠 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 26-199) antibodyIDO 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (N-Term) antibodyIDO 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
: "Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy." in: Nature medicine, Vol. 11, Issue 3, pp. 312-9, (2005) (PubMed).
-
: "Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy." in: Nature medicine, Vol. 11, Issue 3, pp. 312-9, (2005) (PubMed).
-
-
You are here:
